Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy
PHASE1
The most important consideration in the design of this clinical trial is to...
Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma
PHASE1
The purpose of this study is to test the side effects of an investigational...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Evaluation of the Safety and Immunogenicity of Sequential Administration of Prevnar 13⢠and Pneumovax⢠23 in Healthy Participants 50 Years of Age and Older (V110-029)
PHASE3
The purpose of this study is to evaluate the safety and immunogenicity of s...